**Core Concept:** Neurofibromatosis I (NF1) is a rare autosomal dominant genetic disorder characterized by the overgrowth of nerves, leading to the formation of benign tumors (neurofibromas) in the peripheral nerves. The condition is caused by a mutation in the NF1 gene, which encodes neurofibromin, an inhibitor of the RAS/MAPK signaling pathway.

**Why the Correct Answer is Right:** Neurofibromatosis type I is a genetic disorder caused by a mutation in the NF1 gene, which results in reduced or absent neurofibromin protein expression. Neurofibromin is a negative regulator of the RAS/MAPK signaling pathway, a crucial pathway involved in cell growth, differentiation, and survival. In the absence of neurofibromin, the RAS/MAPK pathway remains activated, leading to uncontrolled cell proliferation and formation of benign tumors called neurofibromas.

**Why Each Wrong Option is Incorrect:**

A. This option is incorrect because neurofibromatosis type 1 is caused by a mutation in the NF1 gene, not NF2 gene. NF2 is associated with schwannomas and meningiomas, not neurofibromas.

B. This option is incorrect because neurofibromatosis type 1 is an autosomal dominant genetic disorder, meaning it is inherited from a parent with the mutated NF1 gene. It does not arise due to spontaneous mutations.

C. This option is incorrect because neurofibromatosis type 1 is characterized by the development of benign tumors (neurofibromas) in the peripheral nerves, not malignant tumors. Malignant tumors are associated with neurofibromatosis type 2 (NF2), not NF1.

D. This option is incorrect because neurofibromatosis type 1 is an autosomal dominant disorder, meaning it is inherited from a parent with the mutated NF1 gene. It does not have an age-related onset, as the condition is present from birth.

**Clinical Pearl:** A correct diagnosis of neurofibromatosis type 1 is crucial because it guides treatment and management strategies. Early diagnosis enables proper surveillance for complications, such as optic pathway gliomas, which are malignant tumors and can lead to vision loss if left untreated. Early diagnosis and treatment can prevent severe complications and improve the quality of life for patients.